Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications metabolically healthy obesity risk incident ischemic heart disease stroke ���
… Access and Outcomes Strategy Pharmacoepidemiology and Risk Management Biostatistics Real-World Evidence …
… Ms. Nelson has more than 10 years of project management, risk evaluation and mitigation, change management, and … oncology, women’s health, autoimmune diseases, kidney disease, and respiratory disease. Ms. Nelson has extensive knowledge in developing …
… and others conducted a study to evaluate PsA patients’ disease experiences and treatment preferences. Creation of a … the least. Survey participants were also asked which PsA disease impacts were the most and least important to improve. … activities was ranked as the most important impact of the disease to improve, followed by improving the ability to …
… Xabier Garcia de Albeniz Martinez Pharmacoepidemiology and Risk Management Barcelona, Spain MD, Medical University of …
… gastrointestinal, and gynecological disorders, obesity, sexual dysfunction, bipolar disorder, anxiety, …
Best Practices for Interacting with ICER A systematic review of ICER evaluations from 2008 to 2018: recent trends in evaluation process and lessons learned Ronquest NA, Gould IG, Barnett CL, Mladsi DM Transcript: The Institute for Clinical and Economic …
… hepatitis, sexual dysfunction, acute coronary syndrome, heart failure, atopic dermatitis, rheumatoid arthritis, and …
… fight COVID-19.” Related Services Pharmacoepidemiology and Risk Management Staff Members Alejandro Arana Carla Franzoni …
… methods applied in the therapeutic areas of psychiatry, obesity, and diabetes. These include, but are not limited to, …
… researchers are familiar with DALYs following burden-of-disease studies in Chile. Chilean preferences should be used. … quality of life and utilities can be considered if the disease or the intervention has a significant effect on … if a validated tariff is available for Germany. • Mapping disease-specific instruments to generic instruments is …